Skip to content

Observational Study on the Efficacy of Conventional Migraine Prophylactic Medications in Patients with Vestibular Migraine

Observational Study on the Efficacy of Conventional Migraine Prophylactic Medications in Patients with Vestibular Migraine

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010946
Enrollment
120
Registered
2025-08-27
Start date
2023-08-22
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Jeonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Patients who meet the diagnostic criteria for vestibular migraine or probable vestibular migraine proposed by the Barany Society and the International Headache Society ? Adults aged 18 to 65 years ? Individuals without other neurological abnormal symptoms ? Individuals who understand the study details, can follow instructions, and are able to communicate ? Individuals who voluntarily agree to participate in the study and have signed the consent form

Exclusion criteria

Exclusion criteria: ? Individuals under 19 years of age (minors) ? Individuals diagnosed with other primary or secondary headache disorders ? Individuals showing abnormal findings on neurological examination or neuroimaging ? Individuals with other clinically significant diseases as determined by the investigator (such as cerebrovascular diseases, neurodegenerative diseases, cardiopulmonary diseases, liver diseases, renal diseases, hematologic disorders that may cause bleeding abnormalities, malignant tumors, musculoskeletal disorders, psychiatric disorders, etc.) that make participation in the study difficult ? Women who are pregnant or planning to become pregnant ? Individuals who do not consent to participate in the study ? Other patients deemed inappropriate for participation in this study by the investigator

Design outcomes

Primary

MeasureTime frame
Monthly number of headache and dizziness days and acute medication use days (via visit or telephone), Headache Impact Test-6, Migraine Disability Assessment , Dizziness handicap inventory, Visual Analogue Scale – Dizziness, Motion sickness scale, Vestibular Disorders Activities of Daily Living Scale, Patient Health Questionnaire-9, Generalized Anxiety Disorder-7,

Secondary

MeasureTime frame
Monthly number of headache and dizziness days and acute medication use days (via visit or telephone), Headache Impact Test-6, Migraine Disability Assessment , Dizziness handicap inventory, Visual Analogue Scale – Dizziness, Motion sickness scale, Vestibular Disorders Activities of Daily Living Scale, Patient Health Questionnaire-9, Generalized Anxiety Disorder-7,;Monthly number of headache and dizziness days and acute medication use days (via visit or telephone);Monthly number of headache and dizziness days and acute medication use days (via visit or telephone)

Countries

Korea, Republic of

Contacts

Public ContactSunyoung Oh

Jeonbuk National University

ohsun@jbnu.ac.kr+82-63-250-1590

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026